1. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
   Rossella Fasano et al, 2021, Life CrossRef
2. Engineering In Vitro Organ‐Structured Tumor Model for Evaluating Neoantigen‐Specific T Cell Responses in Hepatocellular Carcinoma
   Jingyu Xiao et al, 2023, Advanced Materials Interfaces CrossRef
3. Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
   Kyoko Oura et al, 2021, International Journal of Molecular Sciences CrossRef
4. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
   Yu Akazawa et al, 2019, World Journal of Meta-Analysis CrossRef
5. Next-Generation Cancer Immunotherapy Targeting Glypican-3
   Yasuhiro Shimizu et al, 2019, Frontiers in Oncology CrossRef
6. Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
   YU SAWADA et al, 2015, International Journal of Oncology CrossRef
7. Developments in cancer vaccines for hepatocellular carcinoma
   null null et al, 2016, Cancer Immunology, Immunotherapy CrossRef
8. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
   Yaojie Fu et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
9. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells
   Yang Liu et al, 2015, Cellular Immunology CrossRef
10. Glypican 3 overexpression in primary and metastatic Wilms tumors
    Maria Tretiakova et al, 2015, Virchows Archiv CrossRef
11. Trial Watch: Peptide-based anticancer vaccines
    Jonathan Pol et al, 2015, OncoImmunology CrossRef
12. Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice
    Xiaoxiao Jin et al, 2022, Cancer Immunology, Immunotherapy CrossRef
13. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
    YULIANG WANG et al, 2015, Molecular Medicine Reports CrossRef
14. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang et al, 2015, Hepatobiliary & Pancreatic Diseases International CrossRef
15. Promising new strategies for hepatocellular carcinoma
    Yasunari Nakamoto, 2017, Hepatology Research CrossRef
16. Cancer immunotherapy‐targeted glypican‐3 or neoantigens
    Yasuhiro Shimizu et al, 2018, Cancer Science CrossRef
17. Trial Watch
    Fernando Aranda et al, 2013, OncoImmunology CrossRef
18. Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
    Yasuhiro Shimizu et al, 2019, Cancer Science CrossRef
19. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review
    Fares E.M. Ali et al, 2024, International Immunopharmacology CrossRef
20. Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers
    My Thi Viet Ha et al, 2023, Cancer Science CrossRef